Collaborate Disseminate
New data announced by Moderna is showing its mRNA COVID-19 vaccine remains significantly effective after six months. However, the company does note that a possible reduction in efficacy in the face of the new Delta variant indicates a likely need for t… Continue reading Moderna says vaccine efficacy strong after six months, but booster likely
The World Health Organization (WHO) has called for a global halt on COVID-19 vaccine booster shots until at least the end of September so supplies can be prioritized for poorer countries with unvaccinated vulnerable populations. The goal, says the WHO,… Continue reading WHO wants COVID-19 vaccine boosters redirected to countries in need
If last year was all about repurposing old drugs to target COVID-19 while developing vaccines, the focus of much research this year is certainly on producing novel antiviral drugs to help treat those sick with the disease. While many have reasonably fo… Continue reading The hunt for an antiviral pill to treat COVID-19 at home
BioNTech, the pioneering mRNA company responsible for one of the world’s first COVID-19 vaccines, is now looking to develop an mRNA malaria vaccine. Working with the World Health Organization the company hopes to begin human clinical trials sometime ne… Continue reading After COVID-19 BioNTech turns its mRNA vaccine tech on malaria
A big flush of funding from the National Institute for Health Research (NIHR) in the United Kingdom is pushing new research on ways to diagnose and treat long COVID. A University of Cambridge team receiving NIHR funding is now working on a blood test t… Continue reading Researchers hunt for a long COVID diagnostic blood test
A new heat-tolerant COVID-19 vaccine has delivered strong preclinical results. The vaccine can remain stable for up to 30 days at around 37 °C (98 °F) and researchers are looking to begin human trials later this year.Continue ReadingCategory: ScienceTa… Continue reading New heat-tolerant COVID-19 vaccine readies for human trials
When will COVID-19 vaccine booster shots be necessary? Pfizer has recently claimed a third booster dose of its vaccine may be needed six to 12 months after full vaccination but not everyone is convinced, with new research finding mRNA vaccines could of… Continue reading To boost or not to boost? The big COVID-19 vaccine question
Through a world-first trial, scientists in the UK have demonstrated the potential of a new vaccine to treat a life-threatening form of meningitis, and it can be delivered via nose drops. The researchers have developed a way of preventing meningococcal … Continue reading Vaccine for bacterial meningitis could be delivered via nose drops
A new study in the journal Science Advances presents the latest research demonstrating the potential effectiveness of an inhalable COVID-19 vaccine. The vaccine is one of several in development designed to be administered through a nasal spray.Continue… Continue reading Several inhalable COVID-19 vaccines move to human trials
Emails obtained by Motherboard show healthcare workers struggling with the VAMS systems and the labyrinthine bureaucracy connected to it. Continue reading CDC Docs Show Confusion During Initial Vaccine Rollout